Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$21.33 - $59.42 $21 - $59
-1 Reduced 25.0%
3 $0
Q3 2022

Nov 14, 2022

SELL
$22.23 - $33.37 $22 - $33
-1 Reduced 20.0%
4 $0
Q2 2022

Aug 10, 2022

SELL
$19.74 - $43.01 $19 - $43
-1 Reduced 16.67%
5 $0
Q1 2022

May 13, 2022

SELL
$36.25 - $52.02 $72 - $104
-2 Reduced 25.0%
6 $0
Q4 2021

Feb 10, 2022

BUY
$43.27 - $65.72 $346 - $525
8 New
8 $0

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.